Company / Free Cash Flow per Share
Kura Oncology, Inc. Free Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.90
FY2025
5-year range
-$1.71 / $1.80
FY2021-FY2025
Trend
-150.2%
vs FY2024
Sector context
#100 of 192
Health Care
What the data says
At $-0.90, Kura Oncology, Inc.'s free cash flow per share ranks #100 of 192 in the Health Care sector. Improved from $-1.71 to $-0.90 over the past 2 years.
Based on SEC 10-K filings.
-0.90 in FY2025.
Improved from $-1.71 to $-0.90 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#100 of 192 in Health CareTop 52% of 192This company -$0.90 Sector average -$19.84
▼
+95.4% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 150.2% year-over-year.
- Ranks #100 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.90 | -150.2% |
| FY2024 | $1.80 | +205.5% |
| FY2023 | -$1.71 | -3.3% |
| FY2022 | -$1.65 | -3.7% |
| FY2021 | -$1.59 | -17.4% |
| FY2020 | -$1.36 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026